• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by IperionX Limited (Amendment)

    2/9/24 9:16:08 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials
    Get the next $IPX alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.1 IPERIONX LTD COMMON STOCK Cusip #Q4789U120 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #Q4789U120 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 21,131,763 Item 6: 0 Item 7: 21,131,763 Item 8: 0 Item 9: 21,131,763 Item 11: 9.431% Item 12: HC Cusip #Q4789U120 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 21,131,763 Item 8: 0 Item 9: 21,131,763 Item 11: 9.431% Item 12: IN Item 1(a). Name of Issuer: IPERIONX LTD Item 1(b). Address of Issuer's Principal Executive Offices: 129 W TRADE STREET, SUITE 1405 Charlotte, NC 28202 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: Q4789U120 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 21,131,763 (b) Percent of Class: 9.431% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 21,131,763 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of IPERIONX LTD. The interest of Fidelity International Discovery Fund, in the COMMON STOCK of IPERIONX LTD, amounted to 18,273,999 shares or 8.156% of the total outstanding COMMON STOCK at December 29, 2023. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company BK * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of IPERIONX LTD at December 29, 2023. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $IPX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IPX

    DatePrice TargetRatingAnalyst
    8/20/2025$64.00Buy
    Roth Capital
    10/10/2024$30.00Buy
    B. Riley Securities
    More analyst ratings

    $IPX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on IperionX with a new price target

    Roth Capital initiated coverage of IperionX with a rating of Buy and set a new price target of $64.00

    8/20/25 8:56:28 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    B. Riley Securities initiated coverage on IperionX with a new price target

    B. Riley Securities initiated coverage of IperionX with a rating of Buy and set a new price target of $30.00

    10/10/24 7:36:38 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    $IPX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IperionX Response to Short Seller Report

    CHARLOTTE, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ:IPX, ASX: IPX)) notes the short seller report released by Spruce Point Capital Management. Consistent with recommended disclosures on short-selling campaigns under ASIC's guidance in Information Sheet 255, IperionX's response is focused on material, verifiable facts relevant to investors and continuous disclosure obligations. IperionX maintains confidentiality, data-security and intellectual-property controls that meet the stringent contracting requirements of the U.S. Department of War (DoW). IperionX remains focused on executing the commercial scale-up of titanium production and manufacturing in Vir

    11/17/25 8:30:00 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    IperionX – September 2025 Quarterly Report

    CHARLOTTE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ:IPX, ASX: IPX)) is pleased to present its quarterly report for the period ending September 30, 2025. Highlights during and subsequent to the end of the quarter include: Commercial operations: production online, with higher production capacity and lower unit costs All planned major manufacturing equipment is online and operational, for both titanium powder production and component manufacturing at the Titanium Manufacturing Campus in Virginia.Process improvements and optimization has lifted nameplate titanium powder production capacity by 60% without additional capital spend, with further increases in p

    10/30/25 8:30:00 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    IperionX Receives a Further $25M in U.S. Government Funding to Accelerate Titanium Production Scale-Up

    U.S. Department of War, through its Industrial Base Analysis and Sustainment program, has obligated an additional US$25 million under IperionX's previously announced US$47.1 million awardIBAS funding supports the build-out of a resilient, fully integrated, and low-cost titanium supply chain - from minerals to metal - strengthening the U.S. defense industrial baseFunds will be applied to the scale-up of production to 1,400 tpa at IperionX's Titanium Manufacturing Campus in VirginiaThe $25.0 million obligation, along with the prior US$12.5 million and US$5.0 million, takes total obligations to US$42.5 million, with the remaining US$4.6 million expected to be obligated over the contract term C

    9/26/25 8:30:00 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    $IPX
    SEC Filings

    View All

    SEC Form 6-K filed by IperionX Limited

    6-K - IPERIONX Ltd (0001898601) (Filer)

    12/1/25 4:10:23 PM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    SEC Form 6-K filed by IperionX Limited

    6-K - IPERIONX Ltd (0001898601) (Filer)

    11/20/25 9:17:40 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    SEC Form 6-K filed by IperionX Limited

    6-K - IPERIONX Ltd (0001898601) (Filer)

    11/17/25 6:01:50 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    $IPX
    Leadership Updates

    Live Leadership Updates

    View All

    IperionX Enhances Board With Appointment of Senior U.S. Directors

    IperionX Limited (IperionX) (NASDAQ:IPX, ASX: IPX)), a leading American titanium metal and critical materials company, is pleased to announce two significant appointments to its Board of Directors, effective from March 17, 2025. Appointment of Tony Tripeny as Non-Executive Director Mr. Tony Tripeny joins IperionX as an independent Non-Executive Director, and brings over 40 years of financial and operational leadership in advanced manufacturing, technology and materials science. Mr. Tripeny's successful 36-year career at Corning Incorporated, a global innovator and leader in advanced materials science, included senior roles of Executive Vice President and Chief Financial Officer, as well

    3/11/25 8:30:00 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    IperionX Appoints Harold Sears as Additive Manufacturing Senior Advisor

    IperionX Limited ("IperionX") (NASDAQ:IPX, ASX: IPX))) is pleased to announce the appointment of Harold Sears as Additive Manufacturing Senior Advisor. IperionX's lower cost, lower carbon and circular titanium metal powder is a critical input to manufacturing a wide range of specialized titanium components. Mr. Sears' appointment as Senior Advisor will increase IperionX's technical capability to rapidly additively manufacture high-quality, low-cost prototype and production titanium components for advanced industries. Mr. Sears brings over 32 years of experience in rapid manufacturing technologies, including 29 years in additive manufacturing. This includes a highly distinguished career at

    2/22/23 8:30:00 AM ET
    $F
    $IPX
    Auto Manufacturing
    Industrials
    Other Metals and Minerals
    Basic Materials

    IperionX Appoints Toby Symonds as Company President

    IperionX Limited ("IperionX" or "Company") (NASDAQ:IPX, ASX: IPX))), a leader in the development of a sustainable and circular titanium metal supply chain, today announced the appointment of Toby Symonds as President of IperionX. Mr. Symonds has worked with IperionX since 2021, first as an advisory board member and then as Chief Strategy Officer. He is a highly experienced executive with more than 30 years of experience across a range of senior roles in operations, sales, strategy, finance and asset management. Mr. Symonds previously served as a senior advisor to private equity, hedge funds and real estate asset managers, including Coliseum Capital Management, Sweetwater Capital Partners

    11/1/22 8:30:00 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    $IPX
    Financials

    Live finance-specific insights

    View All

    IperionX Interim Financial Report for the Six Months Ended December 31, 2024

    IperionX Limited (IperionX) (NASDAQ:IPX, ASX: IPX)) is pleased to present the Interim Financial Report for the six-months ended December 31, 2024, a period of significant development for the company as it commenced production of titanium metal at the Titanium Manufacturing Campus in Halifax County, Virginia, re-shoring an "all-American" domestic supply of titanium. A link to the report can be found here. About IperionX IperionX is a leading American titanium metal and critical materials company – using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions. Our Titan critical minerals

    3/13/25 8:30:00 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    $IPX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by IperionX Limited (Amendment)

    SC 13G/A - IPERIONX Ltd (0001898601) (Subject)

    2/9/24 9:16:08 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    SEC Form SC 13G/A filed by IperionX Limited (Amendment)

    SC 13G/A - IPERIONX Ltd (0001898601) (Subject)

    11/13/23 9:16:15 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    SEC Form SC 13G filed by IperionX Limited

    SC 13G - IPERIONX Ltd (0001898601) (Subject)

    2/14/23 6:03:05 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials